DOCSLIB.ORG

Mad2l2 As a Safeguard for Open Chromatin in Embryonic Stem Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mad2l2 As a Safeguard for Open Chromatin in Embryonic Stem Cells Mad2l2 as a safeguard for open chromatin in embryonic stem cells Dissertation for the award of the degree “Doctor rerum naturalium.” Of the Georg-August-Universität Göttingen within the doctoral program (Genes and Development) of the Georg-August University School of Science (GAUSS) Submitted by: Ali Rahjouei From: Iran Göttingen, 2016 1 Members of the Thesis Committee Reviewer 1: Professor Dr. Michael Kessel Developmental Biology Group, Max Planck Institute for Biophysical Chemistry Reviewer 2: Professor Dr. Wolfgang Fischle Biological and Environmental Sciences & Engineering Division, King Abdullah University of Science and Technology Professor Dr. Tomas Pieler Department of Developmental Biochemistry, University Medical Center Göttingen Members of the Extended Thesis Committee Professor Dr. Ahmed Mansouri Molecular Cell Differentiation Group, Max Planck Institute for Biophysical Chemistry Professor Dr. Detlef Doenecke Department of Molecular Biology, University Medical Center Göttingen Dr. Halyna Shcherbata Gene expression and signaling Biology Group, Max Planck Institute for Biophysical Chemistry Date of the oral June 2016 2 Affirmation: Here I declare that my doctoral thesis entitled “Mad2l2 as a safeguard for open chromatin in embryonic stem cells” has been written independently with no other sources and aids than quoted. Ali Rahjouei, Goettingen, April 2016 3 Contents Acknowledgment ...................................................................................................................................... 6 Summary .................................................................................................................................................. 7 1. Introduction .......................................................................................................................................... 8 1.1. Pluripotency in peri-implantation embryos .................................................................................. 8 1.2. Embryonic stem cells................................................................................................................... 10 1.2.1. Naive embryonic stem cells ..................................................................................................... 10 1.2.2. Metastable or transient ESCs ................................................................................................ 11 1.2.3. Primed ESCs ........................................................................................................................... 12 1.3. Primordial germ cell-like cells ..................................................................................................... 12 1.4. Double strand break (DSB) repair ............................................................................................... 14 1.4.1. Non-homologous end joining ................................................................................................ 14 1.4.2. Homologous recombination.................................................................................................. 15 1.5. The Mitotic arrest deficient 2-like protein 2 (Mad2l2) ............................................................... 16 1.6. Aim/objective of the thesis ......................................................................................................... 17 2. Materials and methods ...................................................................................................................... 18 2.1. Polymerase chain reaction (PCR) ................................................................................................ 18 2.2. Reverse transcriptase – polymerase chain reaction (RT‐PCR) .................................................... 18 2.3. Quantitative PCR (qPCR) ............................................................................................................. 19 2.4.1- MEF (isolation, expansion, freezing, thawing) ..................................................................... 21 2.4.2. Embryonic stem cells ........................................................................................................... 21 2.5. Differentiation of ESCs ................................................................................................................ 22 2.5.1. EpiLCs ................................................................................................................................... 22 2.5.2. PGCLCs ................................................................................................................................. 22 2.6. Cell manipulation ........................................................................................................................ 23 2.6.1. Inhibitor and cisplatin experiments ..................................................................................... 23 2.6.2. Cell transfection ................................................................................................................... 23 2.7. ABC staining ................................................................................................................................ 23 2.8. Immunofluorescence staining ..................................................................................................... 24 2.9. TUNEL assay ................................................................................................................................ 26 2.10. Metaphase chromosome spreads ............................................................................................. 26 2.11. Dot blot ..................................................................................................................................... 27 2.12. Western blotting ....................................................................................................................... 28 2.13. Cryosectioning ........................................................................................................................... 28 2.14. STED microscopy ....................................................................................................................... 29 2.15. Immune precipitation ............................................................................................................... 29 2.16. Cell fractionation ....................................................................................................................... 30 2.17. Flow cytometry ......................................................................................................................... 31 2.18.1. Chromatin immunoprecipitation ........................................................................................... 31 2.19. Bioinformatic analysis ............................................................................................................... 31 2.19.1. For RNA-seq data reanalysis workflow .............................................................................. 31 4 2.19.2. ChIP-seq ............................................................................................................................. 32 3. Results ................................................................................................................................................ 33 3.1. The in vitro differentiation of ESCs towards germ cells .............................................................. 33 3.1.1 Mad2l2-deficient EpiLCs resemble wild-type EpiLCs ............................................................. 35 3.1.2 The differentiation of ESCs under PGCLC-inducing conditions in the presence or absence of Mad2l2 ............................................................................................................................................... 37 3.2. DDR in Mad2l2-deficient murine embryonic fibroblasts............................................................. 46 3.2.1. Mad2l2-deficiency leads to activation of a DDR. ................................................................. 46 3.2.2. Cell proliferation is decreased in Mad2l2-deficient MEFs .................................................... 47 3.2.3. Histone modifications were misregulated in Mad2l2-deficient MEFs after DNA damage. .. 48 3.3. Characterization of Wild-type and Mad2l2-deficient ESCs ......................................................... 49 3.3.1. Mad2l2 is highly expressed in the euchromatin of ESCs ....................................................... 49 3.3.2. Comparison histone 3 modifications in wild-type and mutant ESCs ..................................... 51 3.3.3. No evidence for DNA damage in Mad2l2-deficient ESCs ...................................................... 53 3.3.4. Comparison of transcriptomes from wild-type and Mad2l2-deficient ESCs ......................... 54 3.3.5. Dppa3 is downregulated in Mad2l2-deficient ESCs ............................................................... 57 3.3.6. Increase of DNA methylation in Mad2l2-deficient ESCs ........................................................ 60 3.4. Mechanistic aspects of Mad2l2 function .................................................................................... 63 3.4.1. Absence of Mad2l2 from meiotic testicular cells .................................................................. 63 3.4.2. Mad2l2 interacts with DDR factors directly .......................................................................... 64 3.4.3. Inhibition of histone or DNA modifications by small inhibitors in Mad2l2-deficient
Load more

Recommended publications
  • Ubiquitinated Proliferating Cell Nuclear Antigen Activates Translesion DNA Polymerases ␩ and REV1
    Ubiquitinated proliferating cell nuclear antigen activates translesion DNA polymerases ␩ and REV1 Parie Garg and Peter M. Burgers* Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, 660 South Euclid, St. Louis, MO 63110 Edited by Jerard Hurwitz, Memorial Sloan–Kettering Cancer Center, New York, NY, and approved November 4, 2005 (received for review July 14, 2005) In response to DNA damage, the Rad6͞Rad18 ubiquitin-conjugat- and requiring additional activation by the Cdc7͞Dbf4 protein ing complex monoubiquitinates the replication clamp proliferating kinase that normally functions in cell cycle progression (5, 12). cell nuclear antigen (PCNA) at Lys-164. Although ubiquitination of It is this complex pathway that mainly contributes to DNA PCNA is recognized as an essential step in initiating postreplication damage induced mutagenesis in eukaryotic cells. Although repair, the mechanistic relevance of this modification has remained normally involved in lagging strand DNA replication, the high- elusive. Here, we describe a robust in vitro system that ubiquiti- fidelity Pol ␦ is also required for damage-induced mutagenesis. nates yeast PCNA specifically on Lys-164. Significantly, only those The functions of Pol ␨ and Rev1 appear to be uniquely confined PCNA clamps that are appropriately loaded around effector DNA to mutagenesis. Pol ␨ is an error-prone DNA polymerase that can by its loader, replication factor C, are ubiquitinated. This observa- bypass damage (13). Rev1 is a deoxycytidyl transferase that tion suggests that, in vitro, only PCNA present at stalled replication shows the highest catalytic activity opposite template guanines forks is ubiquitinated. Ubiquitinated PCNA displays the same and abasic sites (14, 15). Rev1 is primarily responsible for replicative functions as unmodified PCNA.
    [Show full text]
  • Jimmunol.0901240.Full.Pdf
    A Critical Role for REV1 in Regulating the Induction of C:G Transitions and A:T Mutations during Ig Gene Hypermutation This information is current as Keiji Masuda, Rika Ouchida, Yingqian Li, Xiang Gao, of September 24, 2021. Hiromi Mori and Ji-Yang Wang J Immunol published online 8 July 2009 http://www.jimmunol.org/content/early/2009/07/08/jimmuno l.0901240 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2009/07/07/jimmunol.090124 Material 0.DC1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 24, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published July 8, 2009, doi:10.4049/jimmunol.0901240 The Journal of Immunology A Critical Role for REV1 in Regulating the Induction of C:G Transitions and A:T Mutations during Ig Gene Hypermutation Keiji Masuda,* Rika Ouchida,* Yingqian Li,†* Xiang Gao,† Hiromi Mori,* and Ji-Yang Wang1* REV1 is a deoxycytidyl transferase that catalyzes the incorporation of deoxycytidines opposite deoxyguanines and abasic sites.
    [Show full text]
  • Identification of Conserved Genes Triggering Puberty in European Sea
    Blázquez et al. BMC Genomics (2017) 18:441 DOI 10.1186/s12864-017-3823-2 RESEARCHARTICLE Open Access Identification of conserved genes triggering puberty in European sea bass males (Dicentrarchus labrax) by microarray expression profiling Mercedes Blázquez1,2* , Paula Medina1,2,3, Berta Crespo1,4, Ana Gómez1 and Silvia Zanuy1* Abstract Background: Spermatogenesisisacomplexprocesscharacterized by the activation and/or repression of a number of genes in a spatio-temporal manner. Pubertal development in males starts with the onset of the first spermatogenesis and implies the division of primary spermatogonia and their subsequent entry into meiosis. This study is aimed at the characterization of genes involved in the onset of puberty in European sea bass, and constitutes the first transcriptomic approach focused on meiosis in this species. Results: European sea bass testes collected at the onset of puberty (first successful reproduction) were grouped in stage I (resting stage), and stage II (proliferative stage). Transition from stage I to stage II was marked by an increase of 11ketotestosterone (11KT), the main fish androgen, whereas the transcriptomic study resulted in 315 genes differentially expressed between the two stages. The onset of puberty induced 1) an up-regulation of genes involved in cell proliferation, cell cycle and meiosis progression, 2) changes in genes related with reproduction and growth, and 3) a down-regulation of genes included in the retinoic acid (RA) signalling pathway. The analysis of GO-terms and biological pathways showed that cell cycle, cell division, cellular metabolic processes, and reproduction were affected, consistent with the early events that occur during the onset of puberty.
    [Show full text]
  • Human Pol Ζ Purified with Accessory Subunits Is Active in Translesion DNA Synthesis and Complements Pol Η in Cisplatin Bypass
    Human Pol ζ purified with accessory subunits is active in translesion DNA synthesis and complements Pol η in cisplatin bypass Young-Sam Lee1, Mark T. Gregory, and Wei Yang2 Laboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892 Contributed by Wei Yang, December 27, 2013 (sent for review December 5, 2013) DNA polymerase ζ (Pol ζ) is a eukaryotic B-family DNA polymerase a nucleotide opposite either a cis–syn thymine or a 6-4 photo- that specializes in translesion synthesis and is essential for normal product (23). Genetic data indicate that a complete lesion bypass embryogenesis. At a minimum, Pol ζ consists of a catalytic subunit event may require two TLS DNA polymerases (24)—one for Rev3 and an accessory subunit Rev7. Mammalian Rev3 contains nucleotide incorporation opposite a lesion (insertion step) and >3,000 residues and is twice as large as the yeast homolog. To the other for the subsequent primer extension (extension step). date, no vertebrate Pol ζ has been purified for biochemical char- The insertion step of TLS is often accomplished by a Y-family acterization. Here we report purification of a series of human Rev3 polymerase, whose active site is uncommonly large, solvent- deletion constructs expressed in HEK293 cells and identification of exposed, and flexible (25). Studies of another B-family TLS DNA a minimally catalytically active human Pol ζ variant. With a tagged polymerase from Escherichia coli (Pol II) show that it efficiently form of an active Pol ζ variant, we isolated two additional acces- extends a DNA primer after a lesion by looping out the damaged sory subunits of human Pol ζ, PolD2 and PolD3.
    [Show full text]
  • Gene Section Review
    Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Gene Section Review MAD2L1 (mitotic arrest deficient 2, yeast, human homolog like-1) Elizabeth M. Petty, Kenute Myrie Division of Medical Genetics Departments of Human Genetics and Internal Medicine University of Michigan Medical School 1150 West Medical Center Drive, 4301 MSRB III, Ann Arbor, Michigan 48109- 0638, USA (EMP, KM) Published in Atlas Database: March 2001 Online updated version : http://AtlasGeneticsOncology.org/Genes/MAD2L1ID304.html DOI: 10.4267/2042/37729 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence. © 2001 Atlas of Genetics and Cytogenetics in Oncology and Haematology Identity Other names: HsMAD2; MAD2; MAD2A HGNC (Hugo): MAD2L1 Shadded boxes (1-5) depict the 5 exons of MAD2L1. The black Location : 4q27 triangle indicates a del A mutation that was found in the CAL51 Local order: As noted on the GM99-GB4 breast cancer cell line. Open triangkes depict the locations of Chromosome 4 map: Position: 548.24 (cR3000) Lod identified sequence variants. Figure is not drawn to scale. score: 1.16 Reference Interval: D4S2945-D4S430 Transcription (115.1-125.1 cM) It is located within the NCBI BAC MAD2L1 has 5 coding exons. No alternative splicing genomic contig: NT_006302.2 which is part of the has been described. Regulation of its transcription in homo sapiens chromosome 4 sequence segment. human cells is currently poorly understood. Note: MAD2L1 was intially (and errounously) mapped by fluorescence in situ hybridization (FISH) to 5q23- Protein q31. Subsequent comprehensive mapping studies using somatic cell hybrid analysis, radiation hybrid (RH) Description mapping, and FISH localized it to 4q27.
    [Show full text]
  • Anti-MAD2L2 Monoclonal Antibody, Clone FQS24768 (DCABH-6886) This Product Is for Research Use Only and Is Not Intended for Diagnostic Use
    Anti-MAD2L2 monoclonal antibody, clone FQS24768 (DCABH-6886) This product is for research use only and is not intended for diagnostic use. PRODUCT INFORMATION Product Overview Rabbit Monoclonal to Mad2L2 Antigen Description Adapter protein able to interact with different proteins and involved in different biological processes. Mediates the interaction between the error-prone DNA polymerase zeta catalytic subunit REV3L and the inserter polymerase REV1, thereby mediating the second polymerase switching in translesion DNA synthesis. Translesion DNA synthesis releases the replication blockade of replicative polymerases, stalled in presence of DNA lesions. May also regulate another aspect of cellular response to DNA damage through regulation of the JNK-mediated phosphorylation and activation of the transcriptional activator ELK1. Inhibits the FZR1- and probably CDC20-mediated activation of the anaphase promoting complex APC thereby regulating progression through the cell cycle. Regulates TCF7L2-mediated gene transcription and may play a role in epithelial-mesenchymal transdifferentiation. Immunogen Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human Mad2L2 aa 150 to the C-terminus. The exact sequence is proprietary.Database link: Q9UI95 Isotype IgG Source/Host Rabbit Species Reactivity Mouse, Rat, Human Clone FQS24768 Purity Protein A purified Conjugate Unconjugated Applications IP, ICC/IF, Flow Cyt, IHC-P, WB Positive Control K562, SW480, Hela, Molt-4 cell lysates, human ovarian carcinoma tissue, Hela cells, Format Liquid Size 100 μl Buffer Preservative: 0.01% Sodium azide; Constituents: 59% PBS, 0.05% BSA, 40% Glycerol 45-1 Ramsey Road, Shirley, NY 11967, USA Email: [email protected] Tel: 1-631-624-4882 Fax: 1-631-938-8221 1 © Creative Diagnostics All Rights Reserved Preservative 0.01% Sodium Azide Storage Store at +4°C short term (1-2 weeks).
    [Show full text]
  • DNA Polymerase Ι Compensates for Fanconi Anemia Pathway Deficiency by Countering DNA Replication Stress
    DNA polymerase ι compensates for Fanconi anemia pathway deficiency by countering DNA replication stress Rui Wanga, Walter F. Lenoirb,c, Chao Wanga, Dan Sua, Megan McLaughlinb, Qianghua Hua, Xi Shena, Yanyan Tiana, Naeh Klages-Mundta,c, Erica Lynna, Richard D. Woodc,d, Junjie Chena,c, Traver Hartb,c, and Lei Lia,c,e,1 aDepartment of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; bDepartment of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; cThe University of Texas MD Anderson Cancer Center University of Texas Health Science Center at Houston Graduate School of Biomedical Sciences, Houston, TX 77030; dDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; and eLife Sciences Institute, Zhejiang University, Hangzhou, China 310058 Edited by Wei Yang, NIH, Bethesda, MD, and approved November 12, 2020 (received for review May 8, 2020) Fanconi anemia (FA) is caused by defects in cellular responses to proteins, required in homologous recombination (FANCD1/ DNA crosslinking damage and replication stress. Given the con- BRCA2, FANCO/RAD51C, FANCJ/BARD1, and FANCR/ stant occurrence of endogenous DNA damage and replication fork RAD51) (22–26). stress, it is unclear why complete deletion of FA genes does not In addition to the direct role in crosslinking damage repair, have a major impact on cell proliferation and germ-line FA patients FA pathway components are linked to the protection of repli- are able to progress through development well into their adult- cation fork integrity during replication interruption that is not hood.
    [Show full text]
  • Y-Family DNA Polymerases in Escherichia Coli
    Y-family DNA polymerases in Escherichia coli The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Jarosz, Daniel F. et al. “Y-family DNA Polymerases in Escherichia Coli.” Trends in Microbiology 15.2 (2007): 70–77. Web. 13 Apr. 2012. © 2007 Elsevier Ltd. As Published http://dx.doi.org/10.1016/j.tim.2006.12.004 Publisher Elsevier Version Final published version Citable link http://hdl.handle.net/1721.1/70041 Terms of Use Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. Review TRENDS in Microbiology Vol.15 No.2 Y-family DNA polymerases in Escherichia coli Daniel F. Jarosz1, Penny J. Beuning2,3, Susan E. Cohen2 and Graham C. Walker2 1 Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA 02139, USA 2 Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA 3 Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA 02115, USA The observation that mutations in the Escherichia coli that is also lexA-independent [4]. This might have genes umuC+ and umuD+ abolish mutagenesis induced particularly important implications for bacteria living by UV light strongly supported the counterintuitive under conditions of nutrient starvation. The SOS response notion that such mutagenesis is an active rather than also seems to be oscillatory at the single-cell level, and this passive process. Genetic and biochemical studies have oscillation is dependent on the umuDC genes [5].
    [Show full text]
  • Ubiquitin and Ubiquitin-Like Proteins Are Essential Regulators of DNA Damage Bypass
    cancers Review Ubiquitin and Ubiquitin-Like Proteins Are Essential Regulators of DNA Damage Bypass Nicole A. Wilkinson y, Katherine S. Mnuskin y, Nicholas W. Ashton * and Roger Woodgate * Laboratory of Genomic Integrity, National Institute of Child Health and Human Development, National Institutes of Health, 9800 Medical Center Drive, Rockville, MD 20850, USA; [email protected] (N.A.W.); [email protected] (K.S.M.) * Correspondence: [email protected] (N.W.A.); [email protected] (R.W.); Tel.: +1-301-435-1115 (N.W.A.); +1-301-435-0740 (R.W.) Co-first authors. y Received: 29 August 2020; Accepted: 29 September 2020; Published: 2 October 2020 Simple Summary: Ubiquitin and ubiquitin-like proteins are conjugated to many other proteins within the cell, to regulate their stability, localization, and activity. These modifications are essential for normal cellular function and the disruption of these processes contributes to numerous cancer types. In this review, we discuss how ubiquitin and ubiquitin-like proteins regulate the specialized replication pathways of DNA damage bypass, as well as how the disruption of these processes can contribute to cancer development. We also discuss how cancer cell survival relies on DNA damage bypass, and how targeting the regulation of these pathways by ubiquitin and ubiquitin-like proteins might be an effective strategy in anti-cancer therapies. Abstract: Many endogenous and exogenous factors can induce genomic instability in human cells, in the form of DNA damage and mutations, that predispose them to cancer development. Normal cells rely on DNA damage bypass pathways such as translesion synthesis (TLS) and template switching (TS) to replicate past lesions that might otherwise result in prolonged replication stress and lethal double-strand breaks (DSBs).
    [Show full text]
  • Molecular Features of Triple Negative Breast Cancer Cells by Genome-Wide Gene Expression Profiling Analysis
    478 INTERNATIONAL JOURNAL OF ONCOLOGY 42: 478-506, 2013 Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis MASATO KOMATSU1,2*, TETSURO YOSHIMARU1*, TAISUKE MATSUO1, KAZUMA KIYOTANI1, YASUO MIYOSHI3, TOSHIHITO TANAHASHI4, KAZUHITO ROKUTAN4, RUI YAMAGUCHI5, AYUMU SAITO6, SEIYA IMOTO6, SATORU MIYANO6, YUSUKE NAKAMURA7, MITSUNORI SASA8, MITSUO SHIMADA2 and TOYOMASA KATAGIRI1 1Division of Genome Medicine, Institute for Genome Research, The University of Tokushima; 2Department of Digestive and Transplantation Surgery, The University of Tokushima Graduate School; 3Department of Surgery, Division of Breast and Endocrine Surgery, Hyogo College of Medicine, Hyogo 663-8501; 4Department of Stress Science, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima 770-8503; Laboratories of 5Sequence Analysis, 6DNA Information Analysis and 7Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639; 8Tokushima Breast Care Clinic, Tokushima 770-0052, Japan Received September 22, 2012; Accepted November 6, 2012 DOI: 10.3892/ijo.2012.1744 Abstract. Triple negative breast cancer (TNBC) has a poor carcinogenesis of TNBC and could contribute to the develop- outcome due to the lack of beneficial therapeutic targets. To ment of molecular targets as a treatment for TNBC patients. clarify the molecular mechanisms involved in the carcino- genesis of TNBC and to identify target molecules for novel Introduction anticancer drugs, we analyzed the gene expression profiles of 30 TNBCs as well as 13 normal epithelial ductal cells that were Breast cancer is one of the most common solid malignant purified by laser-microbeam microdissection. We identified tumors among women worldwide. Breast cancer is a heteroge- 301 and 321 transcripts that were significantly upregulated neous disease that is currently classified based on the expression and downregulated in TNBC, respectively.
    [Show full text]
  • MAD2L2 Monoclonal ANTIBODY
    For Research Use Only MAD2L2 Monoclonal ANTIBODY www.ptgcn.com Catalog Number:67100-1-Ig Basic Information Catalog Number: GenBank Accession Number: CloneNo.: 67100-1-Ig BC015244 2A4C2 Size: GeneID (NCBI): Recommended Dilutions: 1000 μg/ml 10459 WB 1:5000-1:20000 Source: Full Name: IHC 1:500-1:2000 Mouse MAD2 mitotic arrest deficient-like 2 (yeast) Isotype: Calculated MW: IgG2b 211aa,24 kDa Purification Method: Observed MW: Protein A purification 24 kDa Immunogen Catalog Number: AG28233 Applications Tested Applications: Positive Controls: IHC, WB, ELISA WB : HeLa cells; Species Specificity: IHC : human lymphoma tissue; Human, mouse, rat Note-IHC: suggested angen retrieval with TE buffer pH 9.0; (*) Alternavely, angen retrieval may be performed with citrate buffer pH 6.0 MAD family, together with BUB and Mps1,Cdc20k, play roles in the mitotic spindle checkpoint. MAD2L2 is one of the MAD family. It can mediate the second Background Information polymerase switching in translation DNA synthesis by mediating the interaction between the error-prone DNA polymerase zeta catalytic subunit REV3L and the inserter polymerase REV1. Through regulation of the JNK-mediate phosphorylation and activation of the transcriptional activator ELK1, MAD2L2 involves in cellular response to DNA damage. Also it has role in the progression of cell cycle and peithelial-mesenchymal transdifferentiation. Storage: Storage Store at -20ºC. Stable for one year after shipment. Storage Buffer: PBS with 0.1% sodium azide and 50% glycerol pH 7.3. Aliquoting is unnecessary for -20ºC storage For technical support and original validation data for this product please contact: This product is exclusively available under T: 4006900926 E: [email protected] W: ptgcn.com Proteintech Group brand and is not available to purchase from any other manufacturer.
    [Show full text]
  • The Fidelity of Synaptonemal Complex Assembly Is Regulated by A
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Spiral - Imperial College Digital Repository The fidelity of synaptonemal complex assembly is regulated by a signaling mechanism that controls early meiotic progression Nicola Silva1, Nuria Ferrandiz1, Consuelo Barroso1, Silvia Tognetti2, James Lightfoot1,3, Oana Telecan1, Vesela Encheva4, 5, Peter Faull4, Simon Hanni6, Andre 6 4, 5 2 1,* Furger , Ambrosius P. Snidjers , Christian Speck , Enrique Martinez-Perez 1Meiosis group, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK 2DNA replication group, Institute Clinical Sciences, Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK 3Current address: Max Planck Institute for Developmental Biology, 72076 Tubingen, Germany 4Proteomics facility, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, Du Cane Road, London W12 0NN, UK 5Current address: Protein analysis and proteomics, London Research Institute, South Mimms EN6 3LD, UK 6Department of Biochemistry, Oxford University, Oxford OX1 3QU, UK * Corresponding author: Enrique Martinez-Perez phone: 44 (0)208 383 4314 [email protected] Key words: Meiosis, homologue pairing, synapsis, HORMA domain, checkpoint Running title: Quality control of SC assembly 1 Summary Proper chromosome segregation during meiosis requires the assembly of the synaptonemal complex (SC) between homologous chromosomes. However, the SC structure itself is indifferent to homology and poorly understood mechanisms that depend on conserved HORMA-domain proteins prevent ectopic SC assembly. Although HORMA-domain proteins are thought to regulate SC assembly as intrinsic components of meiotic chromosomes, here we uncover a key role for nuclear soluble HORMA-domain protein HTP-1 in the quality control of SC assembly.
    [Show full text]